[{"Assets_0_Q3_USD":174030000.0,"CommonStockSharesOutstanding_0_Q3_shares":26804300.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-119946000.0,"NetIncomeLoss_1_Q3_USD":-49911000.0,"NetIncomeLoss_3_Q3_USD":-141771000.0,"StockholdersEquity_0_Q3_USD":131745000.0,"Ticker":"ESPR","CIK":"1434868","name":"ESPERION THERAPEUTICS, INC.","OfficialName":"Esperion Therapeutics Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"302940173.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181101"}]